JAK2 and hepatocellular carcinoma: As displayed in Figure 8(b), TP53, AKT1, SRC, STAT3, MAPK3, PIK3CA, MAPK1, PIK3R1, HRAS, JUN, VEGFA, HSP90AA1, EGFR, JAK2, MAPK8, and JUN could be the potential target genes for KCMMs in the treatment of HCC.